| abstract |
The invention concerns the use of a netrin selected among netrin-4, mutated netrin-4, netrin-1, netrin Gl or netrin-3, or one of their fragments or a nucleotide sequence encoding one of said netrins or one of said fragments, or an anti-idiotypic antibody of one of said netrins or of one of said fragments, or of a Fab fragment of said anti-idiotypic antibodies, for preparing a medicine for preventing or treating tumoral or non-tumoral pathologies. |